XML 25 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Millions
12 Months Ended
Mar. 15, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Allocated share-based compensation expense   $ 338.0 $ 330.7 $ 287.1
Income tax benefit, release of deferred tax asset valuation allowance     420.2 38.1
Corporate Headquarters Lease        
Gain on partial operating lease termination   158.8   13.6
Cost of revenue        
Allocated share-based compensation expense   23.3 24.7 23.2
Research and development        
Allocated share-based compensation expense [1]   237.6 232.3 190.1
Research and development | President        
Allocated share-based compensation expense $ (6.7)   4.4  
Sales and marketing        
Allocated share-based compensation expense   22.0 22.4 25.0
General and administrative        
Allocated share-based compensation expense   $ 55.1 $ 51.3 $ 48.8
[1] On March 15, 2023, the Company's President resigned, resulting in the reversal of $6.7 million in stock-based compensation expense. Of the total amount reversed, $4.4 million related to expense recognized prior to January 1, 2023.